Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Rate of locoregional recurrence among patients with oropharyngeal squamous cell carcinoma with known HPV status: a systematic review

Research output: Contribution to journalReviewResearchpeer-review

  1. Second primary cancer following primary oral squamous cell carcinoma: a population-based, retrospective study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders

    Research output: Contribution to journalLetterResearchpeer-review

  1. Inter-observer and intra-observer agreement in drug-induced sedation endoscopy — a systematic approach

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Second primary cancer following primary oral squamous cell carcinoma: a population-based, retrospective study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: We aimed to review systematically the literature on locoregional recurrence rates in patients with HPV-positive and -negative oropharyngeal squamous cell carcinoma (OPSCC).Methods: PubMed and Embase databases were systematically searched using key words such as human papillomavirus, oropharyngeal squamous cell carcinoma with local, regional, and locoregional recurrence.Results: Nine studies (2974 patients with known HPV-status, 59% HPV-positive) were included. Among the HPV-positive and -negative patients, 69% and 58% had lymph node metastasis at diagnosis. At a median time to recurrence ranging from 8.4 to 13.2 months among the included studies, we found that a weighted average of 9% and 26% for HPV-positive and -negative patients experienced locoregional recurrence. Overall, the median follow-up time ranged from 21 to 83 months among the included studies.Conclusion: Recurrence rates for HPV-positive and -negative OPSCC patients were 9% and 26%, respectively, equating to an almost three times higher rate of locoregional recurrence among HPV-negative patients compared to HPV-positive patients.

Original languageEnglish
JournalActa Oncologica
Volume59
Issue number9
Pages (from-to)1131-1136
Number of pages6
ISSN0284-186X
DOIs
Publication statusPublished - Sep 2020

ID: 59872569